Persistence Market Research, in its report entitled “The Musculoskeletal Medicine Market”, paves the way for every technological advancement through which the healthcare industry is evolving. While preparing the report, every parameter has been considered – right from the inception of that particular thing in healthcare industry to the end-results and the role modern-day research and technology play therein.

Increasing Demand for Physical and Occupational Therapies Increases Opportunity for Healthcare Providers

Musculoskeletal medicine incorporates spinal column and musculoskeletal disorders associated with sports, occupational injuries and age-related dysfunction. Musculoskeletal medicine is the diagnosis and management of all acute and chronic conditions affecting musculoskeletal system, i.e., muscles, bones, tendons, joints and ligaments and treatment of non-surgical lesions of the musculoskeletal system. Conditions diagnosed by a musculoskeletal expert include soft tissues and muscular injuries, joint injuries, bone disorders, and arthritis and simple or complex pain conditions. Treatment other than medication may include acupuncture, physiotherapy, chiropractic care, therapeutic massage, structured rehabilitation programs and muscle stretching exercise.

Musculoskeletal disorders are common problems distressing the senior population. A better understanding of musculoskeletal diseases may lead to the accomplishment of effective preventive measures, thus reducing public healthcare expenditure and improving the quality of life in the geriatric population. Technological advancements in orthopedic devices with increasing awareness among people may set for unprecedented demand for physical and occupational therapies and medicines and increase opportunities for healthcare suppliers and providers.

Planning Forward? Access sample of Musculoskeletal Medicine market report!  https://www.persistencemarketresearch.com/samples/22906

Increasing Prevalence of Chronic Musculoskeletal Disorder

The World Health Organization estimated that musculoskeletal diseases are the fifth large cause of deaths due to disability. Globally, one in four people report chronic musculoskeletal damages in both developed and developing countries. Musculoskeletal conditions are accountable for a major health problem in the Australian health system, affecting around 31% of the inhabitants, more than 6 million Australians. These conditions consume massive healthcare resources, representing almost 25% of the total cost of illness in the western countries.

Musculoskeletal conditions are the most common reason of physical disability with severe long-term pain. Back pain, joint disorders, osteoarthritis, rheumatoid arthritis and osteoporosis contribute to musculoskeletal diseases, and it has been targeted as a national health priority area with a national action plan by the Department of Health and Ageing. Also, nowadays people are willing to devote time and money to educate themselves about treatment possibilities and generate a personalized care way that will assist them to reduce pain and sustain an active lifestyle.

Factors Driving and Restraining the Musculoskeletal Medicine Market

The global musculoskeletal medicine market is majorly driven by the rise in geriatric population and also by increase in number of orthopedic physicians specialized in sports medicine, joint, hand and spine replacement. Increasing awareness among people regarding the disease and its treatment options and willingness to live longer are also factors contributing to the growth of the market. Similarly, providing advanced academic training to the healthcare professionals of musculoskeletal disorders, such as medical doctors, nurses, occupational therapists, physiotherapists and other allied healthcare professionals, community practitioners and researchers is expected to boost the demand for musculoskeletal medicine and therapies in the global market. Increasing prevalence of bone disorders and joint-related injuries is another factor driving the demand for musculoskeletal medicines across the globe.

However, the use of heavy-duty drugs in treating musculoskeletal pain is both inadequate and contradictory, strong data is needed to support clinical practice, which restricts the growth of the musculoskeletal medicine market in various regions.

Want to know what all technological upgradations lay in the Musculoskeletal Medicine market? Have a look at the “Table of Content” of Musculoskeletal Medicine market report!  https://www.persistencemarketresearch.com/toc/22906

Competition Outlook

Examples of some of the key players identified in the global musculoskeletal medicine market are as follows:

Small-Scale Manufacturers/Providers
  • Actavis Elizabeth
  • Martec USA LLC
  • Acorda Therapeutics
  • Apotex Inc.
  • CorePharma, LLC
Medium-Scale Manufacturers/Providers
  • Sawai Pharmaceutical Co., Ltd
  • Endo International plc
  • Hikma Pharmaceuticals
  • Fresenius Kabi AG
Large-Scale Manufacturers/Providers
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
  • Novartis Pharmaceuticals Corp
  • Hoffmann la Roche Inc
  • Hospira Inc
  • Valeant Pharmaceuticals International, Inc
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.

Planning to enter the arena of Musculoskeletal Medicine market? Prebook our Musculoskeletal Medicine market report!  https://www.persistencemarketresearch.com/checkout/22906

Market Segmentation

By Drug Type
  • Muscle Relaxants
  • Analgesics
  • Disease-modifying antirheumatic drugs (DMARDS)
  • Bisphosphonates
  • Others
By Route of Administration
  • Oral
  • Intravenous
  • Topical
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com